Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.
- DOI
- 10.1080/21645515.2018.1532250
- Published
- 2019
- Container
- Human vaccines & immunotherapeutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/21645515.2018.1532250,
title = {Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.},
author = {Peterson JT and Stacey HL and MacNair JE and Li J and Hartzel JS and Sterling TM and Benner P and Tamms GM and Musey LK},
year = {2019},
journal = {Human vaccines \& immunotherapeutics},
doi = {10.1080/21645515.2018.1532250},
url = {https://doi.org/10.1080/21645515.2018.1532250}
}RIS
TY - JOUR TI - Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. AU - Peterson JT AU - Stacey HL AU - MacNair JE AU - Li J AU - Hartzel JS AU - Sterling TM AU - Benner P AU - Tamms GM AU - Musey LK PY - 2019 JO - Human vaccines & immunotherapeutics DO - 10.1080/21645515.2018.1532250 UR - https://doi.org/10.1080/21645515.2018.1532250 ER -
APA
JT, P., HL, S., JE, M., J, L., JS, H., TM, S., P, B., GM, T., & LK, M. (2019). Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.. Human vaccines & immunotherapeutics. https://doi.org/10.1080/21645515.2018.1532250
Source records
- pubmed · retrieved 2026-09-26T03:26:24.950Z